Back to video list Back to Home How might a partial agonist antipsychotic help in optimising treatment outcomes for patients with schizophrenia? You may also like Mental Health Congress highlights Article The pandemic has permanently changed psychiatry, but perhaps not radically Depression Article Somatic Symptoms of Depression and Its Treatment Depression Article The application of artificial intelligence in the management of depression Schizophrenia Bipolar Article Can neuroimaging lead to the development of biomarkers in schizophrenia?